Defectos en la expresión de cadena zeta (ζ) en un grupo de pacientes con lupus, escleroderma y artritis de inicio tardío, Colombia 2014

Translated title of the contribution: Defects in the Zeta Chain Expression (ζ) in a Group of Patients with SLE, Scleroderma and Late-onset Arthritis, Colombia 2014

Research output: Contribution to JournalResearch Articlepeer-review

Abstract

Introduction: Systemic Lupus Erythematosus (SLE), Scleroderma and late-onset arthritis are autoimmune inflammatory diseases (EIA) characterized by autoantibody production and pres-ence of abnormal T cells which generate defective immune response. The abnormal expression of key signaling molecules in the defective function of T-lymphocytes plays a significant role in the pathogenesis of autoimmune disease. The T-cells exhibit numerous abnormalities TCRζ1 signaling complex, these aberrations result in altered expression of cytokines and some biochemical events involved in the expression of surface molecules. Defects in the complex may be associated TCRζto steroids used in autoimmune disease patients due to their powerful anti- inflammatory activity and immunosuppressive properties. The synthetic corticosteroids such as dexamethasone inhibit the transcriptional activity of some factors such as NFKB and AP-1, which regulate the synthe-sis of certain cytokines and could be involved in the TCRζ synthesis. Material and Methods: A case-control study, with a 1:1 ratio of cases and controls (13:13). Cases were patients with active autoimmune disease (6 patients with SLE, 5 patients with scleroderma and 2 patients with late-onset arthritis), who have not started treatment with corticosteroids. Controls were patients with no autoimmune disease. The diagnosis was made by the criteria established by the American Col-lege of Rheumatology for patients with SLE, scleroderma and late-onset arthritis. A 10 mL sample was obtained by venipuncture whole blood. Total RNA was extracted and RT-PCR was performed using a set of primers flanking a region of 138 base pairs involving exons 2, 3 and 4 of the ζ chain. Results: The values of Z chain amplification showed significant differences in patients with autoim-mune disease (0.8214 ± 0.1787, med = 0.7368) compared with the control group (0.9225 ± 0.1272, med = 0.9830) (p = 0.045, Mann-Withney non-parametric one tailed exact test). Conclusion: We observed a reduced level of in the zeta chain expression in T cells in patients with autoimmune disease without use of corticosteroids.

Key Words: ζ Chain Corticosteroids, T-Cells, Splicing, Lupus Erythematosus (SLE), T-Cell Re-ceptor (TCR), IgG Fraction Crystallizable (Fcγ), Cytokines, Autoimmunity.
Translated title of the contributionDefects in the Zeta Chain Expression (ζ) in a Group of Patients with SLE, Scleroderma and Late-onset Arthritis, Colombia 2014
Original languageSpanish (Colombia)
Pages (from-to)303-3018
Number of pages16
JournalRevista Ciencias de la Salud
Volume12
Issue number3
DOIs
StatePublished - Sep 26 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Immunology

Fingerprint

Dive into the research topics of 'Defects in the Zeta Chain Expression (ζ) in a Group of Patients with SLE, Scleroderma and Late-onset Arthritis, Colombia 2014'. Together they form a unique fingerprint.

Cite this